Patent · US Active

Stabilized insulin-like growth factor polypeptides

US8343918B2 · kind B2 · utility

2Cited by

4References

16Claims

0Family size

Assignee

Novartis AG · CH

Inventors

David Glass · Cambridge, US
Mara Fornaro · Basel, CH

Key dates

Filing date	Jun 6, 2007
Grant date	Jan 1, 2013
Priority date	—
Expiry date	Nov 4, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/65
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to stabilized polypeptides having an IGF-1 or IGF-2 sequence and an E-peptide sequence, where the natural physiological cleavage of the E-peptide from the IGF is prevented.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.